Generation Bio Co. (GBIO) NASDAQ
$4.15 0.45 (12.16%)
Market Cap: $245.97M
As of 03/28/24 02:28 PM EDT. Market open.
Generation Bio Co. (GBIO)
NASDAQ
$4.15
0.45 (12.16%)
Market Cap: $245.97M
As of 03/28/24 02:28 PM EDT. Market open.
generation bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. our unique genewave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the ... read more
generation bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. our unique genewave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the immunogenicity which limits both the number of patients who can be treated and the ability to re-dose them over time. we are a community of creative problem-solvers and independent thinkers. we are guided by strong personal integrity, humility, and the collaborative, learning mindset required to create solutions for patients and their families. to learn more about our efforts to usher in a new generation in medicine, please visit www.generationbio.com or our twitter feed, @lifetimegenetx. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 29, 2024 | Option Exercise | $1.90 | 1,476 | 2,804 | 49,164 | Jan 31, 2024, 04:30 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 29, 2024 | Option Exercise | $1.90 | 1,476 | 2,804 | 385,628 | Jan 31, 2024, 04:30 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 4,897 | 9,353 | 45,619 | Jan 17, 2024, 05:00 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 4,897 | 9,353 | 382,083 | Jan 17, 2024, 05:00 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 4,897 | 9,353 | 243,773 | Jan 17, 2024, 05:00 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 5,478 | 10,463 | 50,259 | Jan 17, 2024, 05:00 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Jan 15, 2024 | Option Exercise | $1.91 | 15,431 | 29,473 | 1,319,732 | Jan 17, 2024, 05:00 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 3,020 | 5,768 | 112,948 | Jan 17, 2024, 05:00 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 3,637 | 6,947 | 12,683 | Jan 17, 2024, 05:00 PM |
Appelhans Dannielle | Director | Dec 08, 2023 | Buy | $1.79 | 7,363 | 13,180 | 7,363 | Dec 11, 2023, 04:30 PM |
Appelhans Dannielle | Director | Dec 08, 2023 | Buy | $1.82 | 637 | 1,159 | 12,637 | Dec 11, 2023, 04:30 PM |
Appelhans Dannielle | Director | Dec 04, 2023 | Buy | $1.50 | 12,000 | 18,000 | 12,000 | Dec 06, 2023, 04:30 PM |
Quinn Anthony G. | Director | Dec 01, 2023 | Buy | $1.41 | 88,495 | 124,778 | 88,495 | Dec 05, 2023, 04:30 PM |
Rowland Charles A Jr | Director | Dec 04, 2023 | Buy | $1.50 | 150,000 | 225,000 | 534,757 | Dec 05, 2023, 04:30 PM |
Rowland Charles A Jr | Director | Dec 01, 2023 | Buy | $1.31 | 192,960 | 252,778 | 384,757 | Dec 05, 2023, 04:30 PM |
Nicholson Donald William | Director | Dec 01, 2023 | Buy | $1.44 | 100,000 | 144,000 | 213,576 | Dec 05, 2023, 04:30 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 1,211 | 3,924 | 107,256 | Oct 17, 2023, 06:00 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 2,183 | 7,073 | 234,539 | Oct 17, 2023, 06:00 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 2,183 | 7,073 | 36,385 | Oct 17, 2023, 06:00 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 2,675 | 8,667 | 39,932 | Oct 17, 2023, 06:00 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Oct 15, 2023 | Option Exercise | $3.24 | 10,395 | 33,680 | 1,288,187 | Oct 17, 2023, 06:00 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 2,183 | 7,073 | 370,404 | Oct 17, 2023, 06:00 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 1,211 | 3,924 | 5,828 | Oct 17, 2023, 06:00 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Aug 23, 2023 | Sale | $4.93 | 3,116 | 15,362 | 2,914 | Aug 25, 2023, 04:35 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 1,211 | 6,152 | 104,342 | Jul 18, 2023, 04:35 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 2,183 | 11,090 | 229,285 | Jul 18, 2023, 04:35 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 1,211 | 6,152 | 6,030 | Jul 18, 2023, 04:35 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 2,183 | 11,090 | 31,131 | Jul 18, 2023, 04:35 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 3,166 | 16,083 | 33,496 | Jul 18, 2023, 04:35 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Jul 15, 2023 | Option Exercise | $5.08 | 7,476 | 37,978 | 1,275,145 | Jul 18, 2023, 04:35 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 2,183 | 11,090 | 365,150 | Jul 18, 2023, 04:35 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Apr 25, 2023 | Sale | $4.61 | 2,914 | 13,434 | 0 | Apr 26, 2023, 04:16 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 1,211 | 5,450 | 101,428 | Apr 18, 2023, 04:24 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 2,183 | 9,824 | 224,031 | Apr 18, 2023, 04:22 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 1,211 | 5,450 | 2,914 | Apr 18, 2023, 04:21 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 2,183 | 9,824 | 25,877 | Apr 18, 2023, 04:19 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 2,183 | 9,824 | 25,877 | Apr 18, 2023, 04:17 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Apr 15, 2023 | Option Exercise | $4.50 | 6,879 | 30,956 | 1,256,068 | Apr 18, 2023, 04:16 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 2,183 | 9,824 | 356,780 | Apr 18, 2023, 04:14 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jan 26, 2023 | Sale | $5.56 | 2,695 | 14,984 | 0 | Jan 27, 2023, 04:22 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 2,578 | 13,148 | 20,623 | Jan 18, 2023, 05:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 2,578 | 13,148 | 218,777 | Jan 18, 2023, 05:02 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 1,430 | 7,293 | 98,514 | Jan 18, 2023, 04:59 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 2,578 | 13,148 | 20,623 | Jan 18, 2023, 04:57 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Jan 15, 2023 | Option Exercise | $5.10 | 8,122 | 41,422 | 1,239,510 | Jan 18, 2023, 04:54 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 2,578 | 13,148 | 351,526 | Jan 18, 2023, 04:52 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 1,430 | 7,293 | 2,695 | Jan 18, 2023, 04:50 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jan 10, 2023 | Sale | $4.57 | 1,865 | 8,523 | 0 | Jan 11, 2023, 04:25 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Jan 09, 2023 | Sale | $5.11 | 1,865 | 9,530 | 95,819 | Jan 10, 2023, 04:57 PM |
Cooper Ronald Harold Wilfred | Director | Jan 05, 2023 | Option Exercise | $5.12 | 9,500 | 48,640 | 9,500 | Jan 09, 2023, 05:23 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Oct 27, 2022 | Sale | $5.03 | 2,914 | 14,657 | 0 | Oct 28, 2022, 04:05 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 1,211 | 6,794 | 2,914 | Oct 18, 2022, 04:46 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 2,184 | 12,252 | 15,763 | Oct 18, 2022, 04:45 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 1,211 | 6,794 | 95,819 | Oct 18, 2022, 04:44 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 2,184 | 12,252 | 213,917 | Oct 18, 2022, 04:43 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 2,184 | 12,252 | 344,801 | Oct 18, 2022, 04:41 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 2,184 | 12,252 | 15,763 | Oct 18, 2022, 04:40 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Oct 15, 2022 | Option Exercise | $5.61 | 10,395 | 58,316 | 1,222,329 | Oct 18, 2022, 04:38 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Sep 29, 2022 | Sale | $5.24 | 2,828 | 14,819 | 0 | Sep 30, 2022, 04:05 PM |
Rowland Charles A Jr | Director | Sep 19, 2022 | Buy | $5.26 | 15,750 | 82,845 | 191,797 | Sep 20, 2022, 04:16 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Sep 15, 2022 | Sale | $5.32 | 4,610 | 24,525 | 2,828 | Sep 19, 2022, 05:33 PM |
Rowland Charles A Jr | Director | Sep 16, 2022 | Buy | $5.48 | 33,481 | 183,476 | 176,047 | Sep 19, 2022, 05:21 PM |
Rowland Charles A Jr | Director | Sep 15, 2022 | Buy | $5.41 | 17,147 | 92,765 | 142,566 | Sep 19, 2022, 05:21 PM |
Rowland Charles A Jr | Director | Sep 14, 2022 | Buy | $5.30 | 5,600 | 29,652 | 125,419 | Sep 15, 2022, 04:07 PM |
Rowland Charles A Jr | Director | Sep 13, 2022 | Buy | $5.20 | 18,784 | 97,752 | 119,819 | Sep 15, 2022, 04:07 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Jul 15, 2022 | Option Exercise | $7.18 | 14,150 | 101,597 | 1,209,286 | Jul 19, 2022, 04:22 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 4,367 | 31,355 | 339,547 | Jul 19, 2022, 04:19 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 4,367 | 31,355 | 10,509 | Jul 19, 2022, 04:16 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 2,422 | 17,390 | 7,438 | Jul 19, 2022, 04:14 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 4,367 | 31,355 | 208,663 | Jul 19, 2022, 04:11 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 4,367 | 31,355 | 10,509 | Jul 19, 2022, 04:09 PM |
Nicholson Donald William | Director | Mar 10, 2022 | Buy | $4.71 | 8,126 | 38,273 | 113,576 | Mar 11, 2022, 04:53 PM |
Nicholson Donald William | Director | Mar 09, 2022 | Buy | $4.79 | 2,293 | 10,983 | 105,450 | Mar 11, 2022, 04:53 PM |
Rhodes Jason P | Director | Sep 29, 2021 | Sale | $24.59 | 16,586 | 407,850 | 608 | Sep 29, 2021, 07:16 PM |
Rhodes Jason P | Director | Sep 28, 2021 | Sale | $25.24 | 13,113 | 330,972 | 16,556 | Sep 29, 2021, 07:16 PM |
Rhodes Jason P | Director | Sep 27, 2021 | Sale | $25.70 | 51,389 | 1,320,697 | 29,645 | Sep 29, 2021, 07:16 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 29, 2021 | Sale | $24.59 | 30 | 738 | 608 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 29, 2021 | Sale | $24.59 | 16,556 | 407,112 | 0 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 28, 2021 | Sale | $25.24 | 24 | 606 | 638 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 28, 2021 | Sale | $25.24 | 13,089 | 330,366 | 16,556 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 27, 2021 | Sale | $25.70 | 95 | 2,442 | 662 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 27, 2021 | Sale | $25.70 | 51,294 | 1,318,256 | 29,645 | Sep 29, 2021, 07:15 PM |
Rhodes Jason P | Director | Sep 24, 2021 | Sale | $25.84 | 28,916 | 747,161 | 80,939 | Sep 24, 2021, 09:02 PM |
Rhodes Jason P | Director | Sep 23, 2021 | Sale | $26.13 | 75,465 | 1,972,127 | 109,802 | Sep 24, 2021, 09:02 PM |
Rhodes Jason P | Director | Sep 22, 2021 | Sale | $25.89 | 30,617 | 792,705 | 185,126 | Sep 24, 2021, 09:02 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 24, 2021 | Sale | $25.84 | 28,862 | 745,765 | 80,939 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 23, 2021 | Sale | $26.13 | 75,325 | 1,968,469 | 109,802 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 22, 2021 | Sale | $25.89 | 30,560 | 791,229 | 185,126 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 24, 2021 | Sale | $25.84 | 54 | 1,395 | 757 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 23, 2021 | Sale | $26.13 | 140 | 3,659 | 811 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 22, 2021 | Sale | $25.89 | 57 | 1,476 | 951 | Sep 24, 2021, 08:59 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Sep 14, 2021 | Option Exercise | $4.59 | 4,500 | 20,655 | 202,654 | Sep 16, 2021, 04:12 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Sep 14, 2021 | Sale | $28.07 | 4,500 | 126,315 | 198,154 | Sep 16, 2021, 04:12 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Sep 10, 2021 | Option Exercise | $4.59 | 3,000 | 13,770 | 201,154 | Sep 14, 2021, 04:02 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Sep 10, 2021 | Sale | $25.97 | 3,000 | 77,910 | 198,954 | Sep 14, 2021, 04:02 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Aug 23, 2021 | Option Exercise | $4.59 | 1,500 | 6,885 | 199,654 | Aug 25, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Aug 23, 2021 | Sale | $25.04 | 1,500 | 37,560 | 198,154 | Aug 25, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Aug 10, 2021 | Option Exercise | $4.59 | 1,500 | 6,885 | 199,654 | Aug 11, 2021, 04:20 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Aug 10, 2021 | Sale | $22.63 | 1,500 | 33,943 | 198,654 | Aug 11, 2021, 04:20 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jul 12, 2021 | Option Exercise | $4.59 | 3,000 | 13,770 | 201,154 | Jul 14, 2021, 04:02 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jul 12, 2021 | Sale | $25.03 | 3,000 | 75,087 | 199,854 | Jul 14, 2021, 04:02 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 08, 2021 | Option Exercise | $5.16 | 3,518 | 18,153 | 330,076 | Jul 12, 2021, 04:02 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 08, 2021 | Sale | $25.20 | 3,518 | 88,670 | 328,447 | Jul 12, 2021, 04:02 PM |
Rhodes Jason P | Director | Jun 24, 2021 | Sale | $25.85 | 31,008 | 801,618 | 4,092 | Jun 28, 2021, 04:57 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 24, 2021 | Sale | $25.86 | 58 | 1,500 | 616 | Jun 28, 2021, 04:56 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 24, 2021 | Sale | $25.85 | 30,950 | 800,119 | 4,092 | Jun 28, 2021, 04:56 PM |
Rhodes Jason P | Director | Jun 21, 2021 | Sale | $24.84 | 63,892 | 1,586,940 | 155,708 | Jun 23, 2021, 08:27 PM |
Rhodes Jason P | Director | Jun 23, 2021 | Sale | $25.36 | 62,609 | 1,587,548 | 59,281 | Jun 23, 2021, 08:27 PM |
Rhodes Jason P | Director | Jun 22, 2021 | Sale | $24.95 | 58,577 | 1,461,479 | 118,651 | Jun 23, 2021, 08:27 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 23, 2021 | Sale | $25.36 | 116 | 2,942 | 719 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 23, 2021 | Sale | $25.36 | 62,493 | 1,584,606 | 59,281 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 22, 2021 | Sale | $24.95 | 108 | 2,695 | 829 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 22, 2021 | Sale | $24.95 | 58,469 | 1,458,784 | 118,651 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 21, 2021 | Sale | $24.84 | 118 | 2,931 | 897 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 21, 2021 | Sale | $24.84 | 63,774 | 1,584,009 | 155,708 | Jun 23, 2021, 08:26 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | May 27, 2021 | Option Exercise | $4.59 | 1,500 | 6,885 | 199,654 | May 28, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | May 27, 2021 | Sale | $34.05 | 1,500 | 51,075 | 198,154 | May 28, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Apr 22, 2021 | Option Exercise | $4.59 | 2,500 | 11,475 | 2,500 | Apr 23, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Apr 22, 2021 | Sale | $33.32 | 2,500 | 83,300 | 0 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 22, 2021 | Option Exercise | $0.60 | 1,500 | 900 | 199,654 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 21, 2021 | Option Exercise | $0.60 | 1,500 | 900 | 199,654 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 22, 2021 | Sale | $34.03 | 1,500 | 51,045 | 198,154 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 21, 2021 | Sale | $31.07 | 1,500 | 46,605 | 198,154 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 16, 2021 | Option Exercise | $0.60 | 1,500 | 900 | 199,654 | Apr 20, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 16, 2021 | Sale | $28.03 | 1,500 | 42,045 | 198,154 | Apr 20, 2021, 04:05 PM |
Rhodes Jason P | Director | Apr 14, 2021 | Sale | $26.61 | 23,413 | 622,995 | 12,874 | Apr 14, 2021, 08:20 PM |
Rhodes Jason P | Director | Apr 13, 2021 | Sale | $25.16 | 43,145 | 1,085,744 | 30,767 | Apr 14, 2021, 08:20 PM |
Rhodes Jason P | Director | Apr 12, 2021 | Sale | $26.15 | 74,124 | 1,938,229 | 77,329 | Apr 14, 2021, 08:20 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 14, 2021 | Sale | $26.61 | 23,413 | 622,995 | 12,874 | Apr 14, 2021, 08:19 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 13, 2021 | Sale | $25.16 | 43,145 | 1,085,744 | 30,767 | Apr 14, 2021, 08:19 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 12, 2021 | Sale | $26.15 | 74,124 | 1,938,229 | 77,329 | Apr 14, 2021, 08:19 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 09, 2021 | Sale | $27.61 | 43,681 | 1,205,948 | 142,814 | Apr 09, 2021, 08:54 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 08, 2021 | Sale | $28.50 | 43,550 | 1,241,241 | 187,554 | Apr 09, 2021, 08:54 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 07, 2021 | Sale | $28.51 | 39,864 | 1,136,671 | 229,807 | Apr 09, 2021, 08:54 PM |
Rhodes Jason P | Director | Apr 09, 2021 | Sale | $27.61 | 43,681 | 1,205,948 | 142,814 | Apr 09, 2021, 08:53 PM |
Rhodes Jason P | Director | Apr 08, 2021 | Sale | $28.50 | 43,550 | 1,241,241 | 187,554 | Apr 09, 2021, 08:53 PM |
Rhodes Jason P | Director | Apr 07, 2021 | Sale | $28.51 | 39,864 | 1,136,671 | 229,807 | Apr 09, 2021, 08:53 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Mar 10, 2021 | Option Exercise | $0.60 | 10,500 | 6,300 | 208,654 | Mar 12, 2021, 04:03 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Mar 10, 2021 | Sale | $34.97 | 10,500 | 367,209 | 204,104 | Mar 12, 2021, 04:03 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Mar 05, 2021 | Option Exercise | $4.59 | 11,267 | 51,716 | 337,825 | Mar 09, 2021, 04:05 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Mar 05, 2021 | Sale | $31.44 | 11,267 | 354,267 | 335,148 | Mar 09, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Mar 03, 2021 | Option Exercise | $4.59 | 3,000 | 13,770 | 3,000 | Mar 05, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Mar 03, 2021 | Sale | $41.38 | 3,000 | 124,140 | 0 | Mar 05, 2021, 04:05 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Mar 01, 2021 | Sale | $37.58 | 10,000 | 375,801 | 1,202,690 | Mar 03, 2021, 04:10 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Mar 01, 2021 | Option Exercise | $4.59 | 2,500 | 11,475 | 2,500 | Mar 03, 2021, 04:10 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Mar 01, 2021 | Sale | $38.84 | 2,500 | 97,099 | 2,300 | Mar 03, 2021, 04:10 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Feb 10, 2021 | Option Exercise | $0.60 | 10,400 | 6,240 | 208,554 | Feb 12, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Feb 10, 2021 | Sale | $34.60 | 10,400 | 359,856 | 205,925 | Feb 12, 2021, 04:05 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Feb 08, 2021 | Option Exercise | $4.59 | 11,267 | 51,716 | 337,825 | Feb 10, 2021, 04:05 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Feb 08, 2021 | Sale | $33.37 | 11,267 | 375,954 | 330,325 | Feb 10, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Feb 02, 2021 | Option Exercise | $4.59 | 2,500 | 11,475 | 2,500 | Feb 04, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Feb 02, 2021 | Sale | $33.05 | 2,500 | 82,625 | 0 | Feb 04, 2021, 04:05 PM |
Angelino Mark D. | CHIEF OPERATING OFFICER | Jan 15, 2021 | Option Exercise | $4.59 | 7,500 | 34,425 | 353,137 | Jan 20, 2021, 04:05 PM |
Angelino Mark D. | CHIEF OPERATING OFFICER | Jan 15, 2021 | Sale | $32.97 | 7,500 | 247,273 | 349,637 | Jan 20, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 14, 2021 | Option Exercise | $4.59 | 2,500 | 11,475 | 2,500 | Jan 15, 2021, 04:06 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 14, 2021 | Sale | $33.09 | 2,500 | 82,725 | 0 | Jan 15, 2021, 04:06 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 14, 2021 | Option Exercise | $0.60 | 5,630 | 3,378 | 203,784 | Jan 15, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 14, 2021 | Sale | $32.54 | 5,630 | 183,212 | 200,944 | Jan 15, 2021, 04:05 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 11, 2021 | Option Exercise | $4.59 | 11,267 | 51,716 | 337,825 | Jan 13, 2021, 04:07 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 11, 2021 | Sale | $27.58 | 11,267 | 310,768 | 331,579 | Jan 13, 2021, 04:07 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 11, 2021 | Option Exercise | $0.60 | 14,820 | 8,892 | 212,974 | Jan 13, 2021, 04:06 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 11, 2021 | Sale | $27.69 | 14,820 | 410,372 | 206,705 | Jan 13, 2021, 04:06 PM |
Nicholson Donald William | Director | Jan 11, 2021 | Buy | $24.50 | 4,081 | 99,985 | 103,157 | Jan 13, 2021, 04:05 PM |
Rowland Charles A Jr | Director | Jan 11, 2021 | Buy | $24.50 | 20,408 | 499,996 | 101,035 | Jan 13, 2021, 04:04 PM |
Angelino Mark D. | Chief Operating Officer | Dec 15, 2020 | Option Exercise | $4.59 | 5,301 | 24,332 | 350,938 | Dec 17, 2020, 04:05 PM |
Angelino Mark D. | Chief Operating Officer | Dec 15, 2020 | Sale | $34.98 | 5,301 | 185,431 | 346,537 | Dec 17, 2020, 04:05 PM |
Stanton Matthew | Chief Scientific Officer | Dec 10, 2020 | Option Exercise | $0.60 | 10,540 | 6,324 | 208,694 | Dec 14, 2020, 04:05 PM |
Stanton Matthew | Chief Scientific Officer | Dec 10, 2020 | Sale | $37.62 | 10,540 | 396,499 | 203,376 | Dec 14, 2020, 04:05 PM |
Angelino Mark D. | Chief Operating Officer | Aug 14, 2020 | Option Exercise | $0.60 | 62,560 | 37,536 | 345,637 | Aug 18, 2020, 04:07 PM |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 1,100,000 | 20,900,000 | 2,112,546 | Jun 18, 2020, 06:02 PM |
Invus Public Equities, L.P. | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 800,000 | 15,200,000 | 2,814,191 | Jun 18, 2020, 06:01 PM |
Rowland Charles A Jr | Director | Jun 16, 2020 | Buy | $19.00 | 30,000 | 570,000 | 80,627 | Jun 18, 2020, 05:30 PM |
Casdin Capital, LLC | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 650,000 | 12,350,000 | 1,611,215 | Jun 18, 2020, 05:29 PM |
Zone Healthcare Holdings, LLC | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 1,918,819 | Jun 17, 2020, 05:00 PM |
Seybold William | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 1,918,819 | Jun 17, 2020, 04:59 PM |
Flynn James E | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 225,000 | 4,275,000 | 1,186,215 | Jun 16, 2020, 02:50 PM |
Owner | Relationship | Date | Value($) |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/29/2024 | 2,804 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/29/2024 | 2,804 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/15/2024 | 9,353 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/15/2024 | 9,353 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/15/2024 | 9,353 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 01/15/2024 | 10,463 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 01/15/2024 | 29,473 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 01/15/2024 | 5,768 |
Paone Antoinette | CHIEF OPERATING OFFICER | 01/15/2024 | 6,947 |
Appelhans Dannielle | Director | 12/08/2023 | 13,180 |
Appelhans Dannielle | Director | 12/08/2023 | 1,159 |
Appelhans Dannielle | Director | 12/04/2023 | 18,000 |
Quinn Anthony G. | Director | 12/01/2023 | 124,778 |
Rowland Charles A Jr | Director | 12/04/2023 | 225,000 |
Rowland Charles A Jr | Director | 12/01/2023 | 252,778 |
Nicholson Donald William | Director | 12/01/2023 | 144,000 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 10/15/2023 | 3,924 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 10/15/2023 | 7,073 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 10/15/2023 | 7,073 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 10/15/2023 | 8,667 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 10/15/2023 | 33,680 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 10/15/2023 | 7,073 |
Paone Antoinette | CHIEF OPERATING OFFICER | 10/15/2023 | 3,924 |
Paone Antoinette | CHIEF OPERATING OFFICER | 08/23/2023 | 15,362 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 07/15/2023 | 6,152 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 07/15/2023 | 11,090 |
Paone Antoinette | CHIEF OPERATING OFFICER | 07/15/2023 | 6,152 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 07/15/2023 | 11,090 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 07/15/2023 | 16,083 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 07/15/2023 | 37,978 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 07/15/2023 | 11,090 |
Paone Antoinette | CHIEF OPERATING OFFICER | 04/25/2023 | 13,434 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 04/15/2023 | 5,450 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/15/2023 | 9,824 |
Paone Antoinette | CHIEF OPERATING OFFICER | 04/15/2023 | 5,450 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 04/15/2023 | 9,824 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 04/15/2023 | 9,824 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 04/15/2023 | 30,956 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 04/15/2023 | 9,824 |
Paone Antoinette | CHIEF OPERATING OFFICER | 01/26/2023 | 14,984 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/15/2023 | 13,148 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/15/2023 | 13,148 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 01/15/2023 | 7,293 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 01/15/2023 | 13,148 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 01/15/2023 | 41,422 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/15/2023 | 13,148 |
Paone Antoinette | CHIEF OPERATING OFFICER | 01/15/2023 | 7,293 |
Paone Antoinette | CHIEF OPERATING OFFICER | 01/10/2023 | 8,523 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 01/09/2023 | 9,530 |
Cooper Ronald Harold Wilfred | Director | 01/05/2023 | 48,640 |
Paone Antoinette | CHIEF OPERATING OFFICER | 10/27/2022 | 14,657 |
Paone Antoinette | CHIEF OPERATING OFFICER | 10/15/2022 | 6,794 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 10/15/2022 | 12,252 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 10/15/2022 | 6,794 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 10/15/2022 | 12,252 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 10/15/2022 | 12,252 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 10/15/2022 | 12,252 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 10/15/2022 | 58,316 |
Paone Antoinette | CHIEF OPERATING OFFICER | 09/29/2022 | 14,819 |
Rowland Charles A Jr | Director | 09/19/2022 | 82,845 |
Paone Antoinette | CHIEF OPERATING OFFICER | 09/15/2022 | 24,525 |
Rowland Charles A Jr | Director | 09/16/2022 | 183,476 |
Rowland Charles A Jr | Director | 09/15/2022 | 92,765 |
Rowland Charles A Jr | Director | 09/14/2022 | 29,652 |
Rowland Charles A Jr | Director | 09/13/2022 | 97,752 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 07/15/2022 | 101,597 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 07/15/2022 | 31,355 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 07/15/2022 | 31,355 |
Paone Antoinette | CHIEF OPERATING OFFICER | 07/15/2022 | 17,390 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 07/15/2022 | 31,355 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 07/15/2022 | 31,355 |
Nicholson Donald William | Director | 03/10/2022 | 38,273 |
Nicholson Donald William | Director | 03/09/2022 | 10,983 |
Rhodes Jason P | Director | 09/29/2021 | 407,850 |
Rhodes Jason P | Director | 09/28/2021 | 330,972 |
Rhodes Jason P | Director | 09/27/2021 | 1,320,697 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/29/2021 | 738 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/29/2021 | 407,112 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/28/2021 | 606 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/28/2021 | 330,366 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/27/2021 | 2,442 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/27/2021 | 1,318,256 |
Rhodes Jason P | Director | 09/24/2021 | 747,161 |
Rhodes Jason P | Director | 09/23/2021 | 1,972,127 |
Rhodes Jason P | Director | 09/22/2021 | 792,705 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/24/2021 | 745,765 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/23/2021 | 1,968,469 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/22/2021 | 791,229 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/24/2021 | 1,395 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/23/2021 | 3,659 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/22/2021 | 1,476 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 09/14/2021 | 20,655 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 09/14/2021 | 126,315 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 09/10/2021 | 13,770 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 09/10/2021 | 77,910 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 08/23/2021 | 6,885 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 08/23/2021 | 37,560 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 08/10/2021 | 6,885 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 08/10/2021 | 33,943 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 07/12/2021 | 13,770 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 07/12/2021 | 75,087 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 07/08/2021 | 18,153 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 07/08/2021 | 88,670 |
Rhodes Jason P | Director | 06/24/2021 | 801,618 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/24/2021 | 1,500 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/24/2021 | 800,119 |
Rhodes Jason P | Director | 06/21/2021 | 1,586,940 |
Rhodes Jason P | Director | 06/23/2021 | 1,587,548 |
Rhodes Jason P | Director | 06/22/2021 | 1,461,479 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/23/2021 | 2,942 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/23/2021 | 1,584,606 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/22/2021 | 2,695 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/22/2021 | 1,458,784 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/21/2021 | 2,931 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/21/2021 | 1,584,009 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 05/27/2021 | 6,885 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 05/27/2021 | 51,075 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 04/22/2021 | 11,475 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 04/22/2021 | 83,300 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/22/2021 | 900 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/21/2021 | 900 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/22/2021 | 51,045 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/21/2021 | 46,605 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/16/2021 | 900 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/16/2021 | 42,045 |
Rhodes Jason P | Director | 04/14/2021 | 622,995 |
Rhodes Jason P | Director | 04/13/2021 | 1,085,744 |
Rhodes Jason P | Director | 04/12/2021 | 1,938,229 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/14/2021 | 622,995 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/13/2021 | 1,085,744 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/12/2021 | 1,938,229 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/09/2021 | 1,205,948 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/08/2021 | 1,241,241 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/07/2021 | 1,136,671 |
Rhodes Jason P | Director | 04/09/2021 | 1,205,948 |
Rhodes Jason P | Director | 04/08/2021 | 1,241,241 |
Rhodes Jason P | Director | 04/07/2021 | 1,136,671 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 03/10/2021 | 6,300 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 03/10/2021 | 367,209 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 03/05/2021 | 51,716 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 03/05/2021 | 354,267 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 03/03/2021 | 13,770 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 03/03/2021 | 124,140 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 03/01/2021 | 375,801 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 03/01/2021 | 11,475 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 03/01/2021 | 97,099 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 02/10/2021 | 6,240 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 02/10/2021 | 359,856 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 02/08/2021 | 51,716 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 02/08/2021 | 375,954 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 02/02/2021 | 11,475 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 02/02/2021 | 82,625 |
Angelino Mark D. | CHIEF OPERATING OFFICER | 01/15/2021 | 34,425 |
Angelino Mark D. | CHIEF OPERATING OFFICER | 01/15/2021 | 247,273 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/14/2021 | 11,475 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/14/2021 | 82,725 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/14/2021 | 3,378 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/14/2021 | 183,212 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/11/2021 | 51,716 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/11/2021 | 310,768 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/11/2021 | 8,892 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/11/2021 | 410,372 |
Nicholson Donald William | Director | 01/11/2021 | 99,985 |
Rowland Charles A Jr | Director | 01/11/2021 | 499,996 |
Angelino Mark D. | Chief Operating Officer | 12/15/2020 | 24,332 |
Angelino Mark D. | Chief Operating Officer | 12/15/2020 | 185,431 |
Stanton Matthew | Chief Scientific Officer | 12/10/2020 | 6,324 |
Stanton Matthew | Chief Scientific Officer | 12/10/2020 | 396,499 |
Angelino Mark D. | Chief Operating Officer | 08/14/2020 | 37,536 |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | 06/16/2020 | 20,900,000 |
Invus Public Equities, L.P. | 10% Owner | 06/16/2020 | 15,200,000 |
Rowland Charles A Jr | Director | 06/16/2020 | 570,000 |
Casdin Capital, LLC | 10% Owner | 06/16/2020 | 12,350,000 |
Zone Healthcare Holdings, LLC | 10% Owner | 06/16/2020 | 7,600,000 |
Seybold William | 10% Owner | 06/16/2020 | 7,600,000 |
Flynn James E | 10% Owner | 06/16/2020 | 4,275,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 3,168,415 | 0.00013% | -5.53% | Other |
YIHENG CAPITAL MANAGEMENT, L.P. | 1,666,181 | 0.32% | Exited | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,077,963 | 0.00019% | 6.54% | Other |
RENAISSANCE TECHNOLOGIES LLC | 689,400 | 0.00176% | 119% | Other |
D. E. SHAW & CO., INC. | 283,108 | 0.00041% | 1033.07% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View